Disruption of focal adhesion kinase and p53 interaction with small molecule compound R2 reactivated p53 and blocked tumor growth.
about
FAK and paxillin, two potential targets in pancreatic cancerFAK in cancer: mechanistic findings and clinical applicationsPan-cancer analysis of TCGA data reveals notable signaling pathways.Identification and functional characterisation of a Schistosoma japonicum insulin-like peptideResearch of shRNAmir inhibitory effects towards focal adhesion kinase expression in the treatment of gastric cancerSuppression of the Insulin Receptors in Adult Schistosoma japonicum Impacts on Parasite Growth and Development: Further Evidence of Vaccine PotentialFocal adhesion kinase and p53 synergistically decrease neuroblastoma cell survival.Identification of Host Insulin Binding Sites on Schistosoma japonicum Insulin ReceptorsTargeting FAK in human cancer: from finding to first clinical trials.Focal adhesion kinase inhibitors in the treatment of metastatic cancer: a patent review.Gene Expression Profiling Identifies Important Genes Affected by R2 Compound Disrupting FAK and P53 Complex.Elucidating the cancer-specific genetic alteration spectrum of glioblastoma derived cell lines from whole exome and RNA sequencing.Molecular Pathways: Endothelial Cell FAK-A Target for Cancer Treatment.Emerging roles of focal adhesion kinase in cancer.Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck CancerEndogenous Control Mechanisms of FAK and PYK2 and Their Relevance to Cancer Development.Inhibiting focal adhesion kinase: A potential target for enhancing therapeutic efficacy in colorectal cancer therapyTargeting Focal Adhesion Kinase Using Inhibitors of Protein-Protein Interactions
P2860
Q26765360-42546857-BFB2-4F2A-9E5A-507666C768CAQ27026533-58D45BB4-54E6-4A89-BA53-D17226FA90F5Q30980050-A4D44AAB-FBB7-4B61-AC46-C27AA7A01006Q33564619-3CC09FC0-3B45-4ACE-A049-9C5AC13C1274Q34993670-B0830C02-71E5-48A8-A858-E4FF98511CE0Q35593046-724753B0-2413-4518-A1F4-15AE3456C508Q35642231-DB27BB02-99B3-489A-9935-8CC4BD19B6C7Q36083417-17D7FF7C-AE99-4406-8A9C-8155F51C7E7EQ38175738-224B053C-987A-4DED-A8F8-1BDA0C25B66DQ38239003-F095684A-F15F-45E2-9F70-32735B4B2170Q38671984-956A2307-2BA5-4930-9C66-165EF64507E5Q38825589-5EF2B878-E31F-403C-85B5-2553DE9FF7A2Q38854580-B79D9D0E-5B33-4599-BFAF-3A8B60D8A762Q39611596-82B9EEEE-3DE9-47BF-8B32-18E545FEC2E4Q41440142-1F81975E-E33E-414C-A6A5-5B27CE1BEFF4Q54976490-CDDB1AA7-D1B5-4846-9C4F-722D10D568C5Q58566672-590F23BE-025A-4B61-9D39-A87AD8C3C325Q58726403-D9A7FCDA-86A2-4B6C-B701-D9BFE95D4748
P2860
Disruption of focal adhesion kinase and p53 interaction with small molecule compound R2 reactivated p53 and blocked tumor growth.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Disruption of focal adhesion k ...... p53 and blocked tumor growth.
@ast
Disruption of focal adhesion k ...... p53 and blocked tumor growth.
@en
Disruption of focal adhesion k ...... p53 and blocked tumor growth.
@nl
type
label
Disruption of focal adhesion k ...... p53 and blocked tumor growth.
@ast
Disruption of focal adhesion k ...... p53 and blocked tumor growth.
@en
Disruption of focal adhesion k ...... p53 and blocked tumor growth.
@nl
prefLabel
Disruption of focal adhesion k ...... p53 and blocked tumor growth.
@ast
Disruption of focal adhesion k ...... p53 and blocked tumor growth.
@en
Disruption of focal adhesion k ...... p53 and blocked tumor growth.
@nl
P2093
P2860
P356
P1433
P1476
Disruption of focal adhesion k ...... p53 and blocked tumor growth.
@en
P2093
Andrew Magis
Baotran Ho
Carl Morrison
David Ostrov
Vita M Golubovskaya
William G Cance
P2860
P2888
P356
10.1186/1471-2407-13-342
P407
P577
2013-07-11T00:00:00Z
P5875
P6179
1049657576